New medical devices in Japan are evaluated for reimbursement by the Chuikyo committee under MHLW. The process involves reviewing clinical efficacy, safety, cost-effectiveness, & alignment with existing healthcare needs. Manufacturers submit evidence, including clinical trial data & economic analysis. Pricing is determined by comparing similar devices or cost-calculation methods within the NHI system.
